5 hours Should JNJ Stock Be in Your Portfolio Ahead of Q3 Earnings? Zacks
JNJ’s Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. It remains to be seen if MedTech sales improved.
Earnings · Johnson & Johnson (JNJ)